BeStock  
Stocks › Biotechnology › ASND

Ascendis Pharma A/S ASND

US equityMarket cap rank #1027Biotechnology
$252.73 −$3.23 (-1.26%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $252.73 0.00%
Open$255.44
Prev close$255.96
Day range$251.55 – $256.65
Volume602.9K
Market cap$16.63B
P/E (TTM)34.7
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings34.7x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average -14.4x

#2366 of 2996 stocks by PE (1 = cheapest)

Price / book10.1x
CheapRich

Above its usual level · 71st percentile, 5-year average -19.2x

#4998 of 5338 stocks by PB (1 = cheapest)

Price / sales12.6x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 181.9x

#4638 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-64x-28x7x42xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$254.19
Price vs. fair value-0.6%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 10.07 – -19.16 71% (pricier than usual) #4998 of 5338 (1 = cheapest)
PE 34.65 26.46 -14.43 100% (pricier than usual) #2366 of 2996 (1 = cheapest)
PS 12.61 7.96 181.90 0% (cheaper than usual) #4638 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ASND.

Sign in to join the discussion.

Scroll to Top